New Content  edit
Get The App!

Scheduled public events:

Check back soon for posted public events.

IMPACT Live GI has reached the maximum number of events available to be scheduled. New event requests cannot be accommodated at this time. Please check back soon for future event opportunities.

Treatment Options for Metastatic Colorectal Cancer
Learning Objectives:
  • Utilize current evidence on the selection and use of biological agents in addition to chemotherapy for first-line treatment in mCRC
  • Evaluate the current clinical evidence for patient selection, earlier use, and optimal dosing of third line agents in patients that failed prior lines of therapy with mCRC
  • Screen patients with advanced colorectal cancer for mismatch repair (MMR) deficiencies, including microsatellite instability-high (MSI-H) mCRC, and discuss plan treatment strategies for patients with MSI-H mCRC
  • Employ the proper adverse event management across a variety of mCRC treatments and discuss how toxicity is a potential marker for activity

Advances in the Management of Metastatic Gastric Cancer
Learning Objectives:
  • Describe current molecular classification subtypes of gastric cancer and perform the appropriate molecular diagnostic testing on all patients with advanced gastric cancer.
  • Evaluate the current evidence on the use of anti-VEGF therapy alone or in combination with chemotherapy in patients with advanced gastric cancer.
  • Evaluate the current evidence on the use immune checkpoint inhibitor therapy, alone or in combination, in the treatment of advance gastric cancer.
  • Discuss the recent Phase 3 safety and efficacy data with trifluridine/tipiracil in the treatment of patients with metastatic gastric cancer and gastroesophageal junction  cancer.

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Metastatic Colorectal Cancer - UAN: JA4008162-9999-19-457-L01-P; 0.5 contact hour; Knowledge
Metastatic Gastric Cancer - UAN: JA4008162-9999-19-458-L01-P; 0.5 contact hour; Knowledge

Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Target Audience
Theses activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with metastatic colorectal and metastatic gastric cancer.

Fee Information
There is no fee for these educational activities.

Jointly provided by Postgraduate Institute for Medicine and Total CME

These activities are supported by an independent educational grant from Taiho Oncology, Inc.

Available Formats

Grand Rounds
Your institution will select a faculty presenter and topic, and provide the in-hospital venue. Rock Solid Meetings and Events with work with an on-site representative to assist with logistical planning as needed.

Dinner Meeting
Held at a restaurant, this program will include the selection of a speaker and topic(s) for a 30-60 minute lecture plus a question-and-answer session. Site selection will comply with ACCME and PhRMA guidelines, and will include a modest meal selection. These are generally private programs for an individual practice group.

Lunch (or breakfast) Meeting
Held at your practice, this program includes a 30-60 minute lecture plus a question-and-answer session. This format will include a modest meal selection, compliant with ACCME and PhRMA guidelines. This program may be for a single practice, or multiple practice groups.

This format may include multiple speakers and lecture topics.

Pre-work Program/ Post-work Quiz
Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Madonna McDonald prior to the live event at 206.890.0644.

Compliance with Sunshine Act
The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT Live programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit


Program Chair

Johanna C. Bendell, MD
Chief Development Officer
Director, Drug Development Unit Nashville
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, TN

Marwan Fakih, MD
Professor, Medical Oncology and Therapeutics Research
Judy and Bernard Briskin Distinguished Directorship in Clinical Research
Medical Director, Briskin Center for Clinical Research
Section Head, GI Medical Oncology
City of Hope Comprehensive Cancer Center
Duarte, CA


Shiraj Sen, MD, PhD
Associate Director, Drug Development Unit
Sarah Cannon Research Institute at HealthONE
Denver, CO

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.